STOCK TITAN

Leadership shifts at Gabelli Fund (NYSE: GCV) as Mario Gabelli recovers

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

The Gabelli Convertible & Income Securities Fund Inc. reports that Mario J. Gabelli, the Fund’s Trustee, Chairman and Chief Investment Officer, was hospitalized for observation and testing following a medical incident on March 19, 2026. His condition is described as improving, but his return date is not yet known.

On March 22, 2026, GAMCO Investors, Inc. activated its long-standing succession plan and named Christopher J. Marangi as President of GAMCO. Day-to-day operations of GAMCO are being led by co-CEO Douglas R. Jamieson and Mr. Marangi, while the Gabelli Value team Co-Chief Investment Officers, Kevin V. Dreyer and Mr. Marangi, lead portfolio management for the Fund during Mr. Gabelli’s absence. The Fund incorporates this information by reference into its effective registration statement.

Positive

  • None.

Negative

  • None.

Insights

Fund discloses founder’s health issue and confirms a pre-planned leadership handoff.

The filing explains that Mario J. Gabelli is temporarily absent after a March 19, 2026 medical incident, with his condition improving but no stated return date. This addresses potential uncertainty around a high-profile portfolio manager and executive.

GAMCO activated a succession plan that had been in place for several years, naming Christopher J. Marangi as President on March 22, 2026. Operational leadership is shared by co-CEO Douglas R. Jamieson and Mr. Marangi, while portfolio management for the Fund is handled by Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Mr. Marangi.

The disclosure indicates continuity in both corporate management and portfolio oversight, suggesting that existing structures were designed to function during Mr. Gabelli’s absence. Actual business and performance effects, if any, would be evaluated through future fund reports and updates.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Medical incident date March 19, 2026 Date of Mario J. Gabelli’s reported medical incident
Succession plan activation March 22, 2026 Date GAMCO implemented its succession plan
Form 8-K date May 7, 2026 Date of the current disclosure by the fund
succession plan financial
"On March 22, 2026, GAMCO... implemented GAMCO’s succession plan that has been in place for several years."
Chief Investment Officer – Value Portfolios financial
"Chief Investment Officer – Value Portfolios of GAMCO Investors, Inc. and Chief Investment Officer – Value Portfolios of Gabelli Funds, LLC"
emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
registration statement regulatory
"The Fund incorporates the information included in this Item 8.01 by reference into its effective Registration Statement."
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
false 0000845611 0000845611 2026-05-07 2026-05-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) May 7, 2026

 

 

 

The Gabelli Convertible & Income Securities Fund Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   811-05715   13-3523423

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

One Corporate Center, Rye, New York   10580
(Address of principal executive offices)   (Zip Code)

 

Registrants telephone number, including area code (800) 422-3554

 

 

(Former name or former address, if changed since last report.)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   GCV   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

 Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01.Other Events

 

As previously announced by GAMCO Investors, Inc. (“GAMCO”) on March 23, 2026, Mario J. Gabelli (“Mr. Gabelli”),Trustee, Chairman and Chief Investment Officer of the Fund, and Chairman, Co-Chief Executive Officer, and Chief Investment Officer – Value Portfolios of GAMCO Investors, Inc. and Chief Investment Officer – Value Portfolios of Gabelli Funds, LLC and GAMCO Asset Management, Inc., was admitted to the hospital for observation and testing after a medical incident March 19, 2026, following a busy day of events around New York City. His condition is improving and he is on the road to recovery, but the timeline for his return is not yet known.

 

On March 22, 2026, GAMCO, the parent company of the Fund’s adviser, Gabelli Funds, LLC (the “Adviser”), implemented GAMCO’s succession plan that has been in place for several years. In accordance with that plan, Christopher J. Marangi was named President of GAMCO on March 22, 2026.

 

While the timeline for Mr. Gabelli’s return remains undetermined, the day-to-day operations of GAMCO will continue to be led by co-CEO, Douglas R. Jamieson, and Christopher J. Marangi.

 

The Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi lead the portfolio management team for the Fund during Mr. Gabelli’s absence.

 

The Fund incorporates the information included in this Item 8.01 by reference into its effective Registration Statement.

 

Item 9.01Financial Statements and Exhibits.

 

(d)Exhibits

 

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  THE GABELLI CONVERTIBLE AND INCOME SECURITIES FUND INC.
     
Date: May 7, 2026 By: /s/ John C. Ball
  Name: John C. Ball
  Title: President and Treasurer

 

2

FAQ

What did GCV disclose about Mario J. Gabelli’s current status?

The fund disclosed that Mario J. Gabelli was hospitalized for observation and testing after a March 19, 2026 medical incident. His condition is improving and he is described as being on the road to recovery, although the timeline for his return is not yet known.

How has GAMCO’s leadership structure changed according to the GCV filing?

On March 22, 2026, GAMCO activated a long-standing succession plan and named Christopher J. Marangi as President. Day-to-day operations of GAMCO are being led by co-CEO Douglas R. Jamieson together with Mr. Marangi during Mario J. Gabelli’s absence.

Who is managing The Gabelli Convertible & Income Securities Fund’s portfolio during Gabelli’s absence?

The fund states that the Gabelli Value team Co-Chief Investment Officers, Kevin V. Dreyer and Christopher J. Marangi, lead the portfolio management team during Mario J. Gabelli’s absence. This reflects the activation of GAMCO’s succession planning arrangements around portfolio oversight.

When was GAMCO’s succession plan for GCV’s adviser implemented?

GAMCO implemented its succession plan on March 22, 2026, following Mario J. Gabelli’s March 19 medical incident. That plan, which had been in place for several years, included naming Christopher J. Marangi as President of GAMCO Investors, Inc. as part of the transition.

How does this disclosure relate to GCV’s registration statement?

The fund states that it incorporates the information in this report by reference into its effective registration statement. This means the described leadership arrangements and Mr. Gabelli’s temporary absence are now formally part of the offering-related disclosure for the fund.

Filing Exhibits & Attachments

3 documents